Sodium Valproate — CAS 1069-66-5

Sodium Valproate is the sodium salt of valproic acid, a broad-spectrum anticonvulsant and mood-stabilizing drug. It is used in the treatment of epilepsy, bipolar disorder, and migraine prevention. Mediocon Inc manufactures GMP-compliant Sodium Valproate API at its Aurangabad facility to international pharmacopoeial standards.

• Epilepsy and seizure disorders
• Bipolar disorder management
• Migraine prophylaxis
• Mood stabilization therapy

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support